Compare Enveric Biosciences Inc (ENVB) vs Levi Strauss & Co. (LEVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Levi Strauss & Co. — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Levi Strauss & Co. trades at $24.47 (market cap $9.19B). The key difference: Levi Strauss & Co. is far larger — about 1727.4× Enveric Biosciences Inc's market cap, and Levi Strauss & Co. pays a 2.68% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | LEVI | |
|---|---|---|
Market Cap | $5.32M | $9.19B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $24.83 |
52-Week Low | $1.28 | $17.92 |
Enterprise Value | $408.82K | $10.51B |
Dividend Yield | — | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Levi Strauss & Co. (LEVI) trades at $23.79, down 1.65% on the day, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $0.28, beating expectations of $0.24, and raised its full-year outlook. Analyst consensus is strongly bullish with 15 buy ratings and a $28.00 price target. Recent dividend increases and robust digital strategy execution highlight operational strength, though stock performance faces near-term pressure from tariff and forex concerns.
Outlook remains positive with earnings momentum and strategic initiatives driving growth, but investors face risks from macroeconomic volatility and competitive pressures. The stock offers potential upside to consensus targets if execution continues, though technical weakness suggests cautious entry timing. Balanced risk-reward with fundamental support outweighing short-term sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →
